Enrollment Completed for Phase 2 Trial of Aquinox Pharmaceuticals’s Potential New Drug to Treat COPD Exacerbations
COPD, News
Aquinox Pharmaceuticals, a Canadian based pharmaceutical company that focuses on the discovery and development of drug therapies for cancer and inflammatory conditions, announced on Monday that they had reached their ... Read more